Medical Management of Diabetes and Heart Disease - part 5 pot
Medical Management of Diabetes and Heart Disease - part 5 pot
... (IRS-1 and IRS-2), and activation of the phosphoinositol 3′ kinase
(PI-3′-K) pathway. On the other hand, cell growth and differentiation are regu-
lated primarily by the SHC, GRB-2, and the MAP-kinase ... insulin
resistant, and perhaps as many as 25% of overweight/obese individuals are nor-
8
Detection and Diagnosis of
Syndromes of Insulin Resistance
and of Diabetes...
Medical Management of Diabetes and Heart Disease - part 10 potx
... Professor of Biochemistry at the University of Vermont College
of Medicine and Physician-in-Chief, Fletcher Allen Health Care, Burlington, Ver-
mont. The editor of Medical Management of Heart Disease ... factors, 157
CHD, 130
dyslipidemia, 154 – 155
hypertension, 152 – 153 , 157
impaired glucose tolerance, type 2 dia-
betes, 150 – 152
inhibin, 153 – 154
insulin resist...
Medical Management of Diabetes and Heart Disease - part 1 pps
... 10016
tel: 21 2-6 9 6-9 000; fax: 21 2-6 8 5- 4 54 0
Eastern Hemisphere Distribution
Marcel Dekker AG
Hutgasse 4, Postfach 812, CH-4001 Basel, Switzerland
tel: 4 1-6 1-2 6 1-8 482; fax: 4 1-6 1-2 6 1-8 896
World Wide ... Hodis, and Wendy J. Mack
12. Management of Patients with Diabetes and Coronary Artery
Disease 1 85
William E. Boden
13. Pathophysiology and...
Medical Management of Diabetes and Heart Disease - part 2 pps
... Report of the expert committee on the diagnosis and classification of diabetes melli-
tus. Diabetes Care 2001; 24(suppl 1):S5–S20.
2. Wingard DL, Barrett-Cannor E. Heart disease and diabetes. In: Diabetes ... ischemic heart disease. JAMA 1998; 279:1 955 –1961.
52 . Kannel WB. Lipids, diabetes, and coronary heart disease: Insights from the Framing-
ham Study. Am He...
Medical Management of Diabetes and Heart Disease - part 3 ppt
... regard, PAI-1 levels have been found to be elevated in both type 1
and 2 diabetes (50 ,51 ) and in hypertension (52 ).
Platelet adhesion and aggregation are increased in both diabetes and hyper-
tension ... 55 :339–340.
77. Rebuffe-Scrive M, Andersson B, Olbe L, Bjorntorp P. Metabolism of adipose tissue
in intraabdominal depots of nonobese men and women. Metabolism 1989; 38...
Medical Management of Diabetes and Heart Disease - part 4 docx
... 55 –80 5 15 10–20
IDL 1.006–1.019 5 10 ϫ 10
6
25 35 20 50 20–40 15 25
LDL 1.019–1.063 2.3 ϫ 10
6
18– 25 5– 15 40 50 20– 25
HDL 1.063–1.21 1.7–3.6 ϫ 10
6
5 12 5 10 15 25 20–30
Density: g/dL; MW: daltons; ... poor
glycemic control
↓ 10– 15%
Metformin ↓ 5 15% Little or no effect Little or no effect
(↑ Ͻ 5% )
TZDs
a
↓ 5 25% ; possible ↑ 5 15% ; possible ↑ 10– 15%
variability by...
Medical Management of Diabetes and Heart Disease - part 6 pdf
... sensitivity and abdominal obesity in
African-American, Hispanic, and non-Hispanic white men and women. The insulin
resistance and atherosclerosis study. Diabetes 1996; 45: 154 7– 155 5.
28. Laws ... resected
in 1 956 to 19 65: a long-term follow-up focusing on natural history and circulating
hormones. Fertil Steril 1992; 57 :50 5 51 3.
18. Edelstein SL, Knowler WC, Bain RP, Andre...
Medical Management of Diabetes and Heart Disease - part 7 pps
... lev-
els of high-density-lipoprotein (HDL) cholesterol, and increased low-density-li-
poprotein (LDL) cholesterol, hypertension, and central obesity with an increased
waist-to-hip ratio. Many cross-sectional ... as second-line therapy or as part of
combination therapy.
Approximately 80% of diabetic subjects will die of cardiovascular disease
and more than half of those wit...
Medical Management of Diabetes and Heart Disease - part 9 docx
... at 5 years in PTCA- and CABG-treated patients even in subgroups of
diabetes and three-vessel disease (31). In addition to the randomized trials com-
paring PCI and CABG, three large, single-center ... the treatment of diabetes and the change
in focus toward aggressive management of blood glucose and lipids, one aspect
of management has not changed: the patient st...
Từ khóa: